A clinical trial analyzed the expression levels of HOTAIR and expression levels of midkine, a heparin‐binding growth factor related to tumor stage progression, in liquid biopsy of patients and healthy individuals to determine the potential of HOTAIR and midkine as biomarkers in thyroid cancer (NCT03469544). The gene discussed is MDK; the disease is thyroid cancer.